Ivax Launch Of Generic Neurontin Raises Eyebrows
Ivax said Wednesday that it was carrying out only a "limited" launch to a small number of buyers, most likely pharmacy-benefit managers and managed-care organizations.
Under most state pharmacy laws, Ivax's generic tablet may not technically be substitutable for Pfizer's Neurontin in the same strengths, given that it is a tablet formulation...
Already a subscriber? Click here to login